Treace Medical Concepts, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Treace Medical Concepts, Inc. (TMCI) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-07
- Treace Medical Concepts, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $1.67M, a 29.81% increase year-over-year.
- Treace Medical Concepts, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$608.00K.
- Treace Medical Concepts, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$697.00K.
- Treace Medical Concepts, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $615.00K.
- Treace Medical Concepts, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$166.00K.
- Treace Medical Concepts, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$2.19M, a 280.66% decline from fiscal 2023.
- Treace Medical Concepts, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $1.21M, a 81.14% increase from fiscal 2022.
- Treace Medical Concepts, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $668.00K, a 72.36% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.06M 10-Q · filed 2026-08-07 | $363.00K derived: sum of 3 quarters · filed 2026-08-07 | $978.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$608.00K 10-Q · filed 2026-05-08 | -$1.30M derived: sum of 2 quarters · filed 2026-05-08 | -$690.00K derived: sum of 3 quarters · filed 2026-05-08 | $595.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$697.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$82.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.20M derived: sum of 3 quarters · filed 2026-08-07 | -$166.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | $615.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.90M derived: sum of 2 quarters · filed 2026-08-07 | $531.00K 10-Q · filed 2025-11-06 | -$817.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$84.00K 10-Q · filed 2026-08-07 | -$1.43M derived: sum of 3 quarters · filed 2026-08-07 | -$2.08M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$1.37M 10-Q · filed 2026-05-08 | -$2.72M derived: sum of 2 quarters · filed 2026-05-08 | -$3.37M derived: sum of 3 quarters · filed 2026-05-08 | -$5.05M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$2.00M derived: sum of 2 quarters · filed 2026-02-27 | -$3.68M derived: sum of 3 quarters · filed 2026-02-27 | -$2.19M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$653.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.33M derived: sum of 2 quarters · filed 2025-11-06 | -$838.00K 10-Q · filed 2025-11-06 | -$656.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$185.00K 10-Q · filed 2025-08-07 | -$3.00K derived: sum of 3 quarters · filed 2026-02-27 | -$616.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $1.50M 10-Q · filed 2025-05-08 | $1.68M derived: sum of 2 quarters · filed 2026-02-27 | $1.06M derived: sum of 3 quarters · filed 2026-02-27 | $1.74M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$431.00K derived: sum of 2 quarters · filed 2026-02-27 | $247.00K derived: sum of 3 quarters · filed 2026-02-27 | $1.21M 10-K · filed 2026-02-27 |
| 2023-09-30 | -$613.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $65.00K derived: sum of 2 quarters · filed 2024-11-05 | $1.03M 10-Q · filed 2024-11-05 | $638.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $678.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $1.64M 10-Q · filed 2024-08-06 | $1.25M derived: sum of 3 quarters · filed 2025-02-27 | $1.27M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $963.00K 10-Q · filed 2024-05-07 | $573.00K derived: sum of 2 quarters · filed 2025-02-27 | $592.00K derived: sum of 3 quarters · filed 2025-02-27 | $2.86M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$390.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$371.00K derived: sum of 2 quarters · filed 2025-02-27 | $1.90M derived: sum of 3 quarters · filed 2025-02-27 | $668.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.29M derived: sum of 2 quarters · filed 2023-11-09 | $1.06M 10-Q · filed 2023-11-09 | $307.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.04M 10-Q · filed 2023-08-09 | $288.00K derived: sum of 3 quarters · filed 2024-02-27 | $537.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$1.23M 10-Q · filed 2023-05-09 | -$1.98M derived: sum of 2 quarters · filed 2024-02-27 | -$1.74M derived: sum of 3 quarters · filed 2024-02-27 | $805.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$751.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$502.00K derived: sum of 2 quarters · filed 2024-02-27 | $2.04M derived: sum of 3 quarters · filed 2024-02-27 | $2.42M 10-K · filed 2024-02-27 |
| 2021-09-30 | $249.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.79M derived: sum of 2 quarters · filed 2022-11-09 | $3.17M 10-Q · filed 2022-11-09 | $3.13M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $2.92M 10-Q · filed 2022-08-10 | $2.88M derived: sum of 3 quarters · filed 2023-03-08 | $3.20M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-03-31 | $379.00K 10-Q · filed 2022-05-06 | $344.00K derived: sum of 2 quarters · filed 2023-03-08 | $660.00K derived: sum of 3 quarters · filed 2023-03-08 | $629.00K derived: sum of 4 quarters · filed 2023-03-08 |
| 2020-12-31 | -$35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $281.00K derived: sum of 2 quarters · filed 2023-03-08 | $250.00K derived: sum of 3 quarters · filed 2023-03-08 | $103.00K 10-K · filed 2023-03-08 |
| 2020-09-30 | $316.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $285.00K derived: sum of 2 quarters · filed 2021-11-04 | $138.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$178.00K 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | -$147.00K 10-Q · filed 2021-05-25 | |||
| 2019-12-31 | $94.00K 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |